GVON Research Collaborative Network.
GVON has been at the forefront of oncology research, dedicated to advancing treatments and improving patient outcomes. Through numerous studies, we strive to innovate and find new solutions that enhance the quality of life for cancer patients worldwide.
Pakistan-Origin Oncology: Statistics, Clinical Trials, and International Standards
- Overview of Pakistan's Clinical Trial Landscape
- Role and Regulations by DRAP (Drug Regulatory Authority of Pakistan)
- Challenges and Opportunities in Oncology Clinical Research
- Published National Cancer Statistics
- Key Cancer Types and Incidence Rates
- Comparison with Global Cancer Trends
- Definitions of Key Terms (e.g., Phase I-IV, ORR, PFS, OS)
- Trial Designs (e.g., Randomised Controlled Trials, Single-Arm Trials, Basket Trials)
- Response Evaluation Criteria (e.g., RECIST 1.1, iRECIST)
- Toxicity Grading (e.g., CTCAE)
- Quality of Life (QoL) Instruments (e.g., EORTC QLQ-C30)
- Overview of International Guidelines (e.g., ICH-GCP)
- Major Trial Groups and Networks (e.g., NCI, EORTC, SWOG
- Opportunities for Pakistan’s Integration into Global Research